Get the Stockscreener App
19.28
127.00%
10.76
Olema Pharmaceuticals Inc stock is traded at $19.28, with a volume of 67.32M.
It is up +127.00% in the last 24 hours and up +106.62% over the past month.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
See More
Previous Close:
$8.52
Open:
$26.455
24h Volume:
67.32M
Relative Volume:
31.35
Market Cap:
$584.98M
Revenue:
-
Net Income/Loss:
$-96.66M
P/E Ratio:
-8.9674
EPS:
-2.15
Net Cash Flow:
$-83.73M
1W Performance:
+136.14%
1M Performance:
+106.62%
6M Performance:
+310.62%
1Y Performance:
+124.10%
1-Day Range:
$18.11
$27.17
1-Week Range:
$7.82
$27.17
52-Week Range:
$2.86
$27.17
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Name
Olema Pharmaceuticals Inc
Sector
Industry
Phone
(415) 651-3316
Address
780 BRANNAN STREET, SAN FRANCISCO
Compare OLMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
19.33 | 584.98M | 0 | -96.66M | -83.73M | -2.15 |
|
ARGX
Argen X Se Adr
|
914.34 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.31 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
198.96 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.94 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.15 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-25 | Initiated | Guggenheim | Buy |
| Aug-12-25 | Reiterated | Citigroup | Buy |
| Apr-02-24 | Initiated | Goldman | Buy |
| Jan-30-24 | Initiated | Citigroup | Buy |
| Jul-21-23 | Initiated | Oppenheimer | Outperform |
| May-05-23 | Initiated | CapitalOne | Overweight |
| Feb-22-23 | Initiated | Credit Suisse | Outperform |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Jun-09-22 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-28-22 | Initiated | H.C. Wainwright | Neutral |
| Dec-07-21 | Resumed | Cowen | Outperform |
| Dec-14-20 | Initiated | Canaccord Genuity | Buy |
| Dec-14-20 | Initiated | Cowen | Outperform |
| Dec-14-20 | Initiated | JP Morgan | Overweight |
| Dec-14-20 | Initiated | Jefferies | Buy |
View All
Olema Pharmaceuticals Inc Stock (OLMA) Latest News
Olema Pharmaceuticals, Inc. $OLMA Holdings Raised by Persistent Asset Partners Ltd - MarketBeat
How sustainable is Olema Pharmaceuticals Inc. stock dividend payoutChart Signals & Free Fast Gain Swing Trade Alerts - newser.com
Can Olema Pharmaceuticals Inc. stock double in next 5 yearsAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Forecasting Olema Pharmaceuticals Inc. price range with options dataJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
What Fibonacci levels say about Olema Pharmaceuticals Inc. reboundWeekly Stock Recap & High Return Stock Watch Alerts - newser.com
News impact scoring models applied to Olema Pharmaceuticals Inc.Portfolio Return Summary & Detailed Earnings Play Alerts - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 6.3%Time to Buy? - MarketBeat
Sector ETF performance correlation with Olema Pharmaceuticals Inc.Trend Reversal & High Conviction Trade Alerts - newser.com
What Wall Street predicts for Olema Pharmaceuticals Inc. stock pricePortfolio Profit Report & Community Verified Watchlist Alerts - Fundação Cultural do Pará
How to build a dashboard for Olema Pharmaceuticals Inc. stockBreakout Watch & Verified High Yield Trade Plans - newser.com
FY2025 Earnings Estimate for OLMA Issued By Lifesci Capital - MarketBeat
Analysts Set Expectations for OLMA FY2025 Earnings - MarketBeat
Will Olema Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Update & Stepwise Trade Signal Guides - Fundação Cultural do Pará
Olema Pharmaceuticals Inc. stock momentum explainedTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 7.2% After Earnings Miss - MarketBeat
Olema Pharmaceuticals Inc Stock Analysis and ForecastPrice Support Zones & High Profit Market Ideas - earlytimes.in
Why Olema Pharmaceuticals Inc. stock could rally in 2025Trade Volume Summary & Safe Entry Zone Tips - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - TipRanks
Will Olema Pharmaceuticals Inc. continue its uptrend2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Olema Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Olema Oncology (OLMA) Advances Cancer Treatment Trials - GuruFocus
Olema Pharma Q3 net loss widens - MarketScreener
[10-Q] Olema Pharmaceuticals, Inc. Quarterly Earnings Report | OLMA SEC FilingForm 10-Q - Stock Titan
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event | OLMA SEC FilingForm 8-K - Stock Titan
Olema (NASDAQ: OLMA) reports $329M cash, starts OPERA-02 and Pfizer combo study - Stock Titan
Will Olema Pharmaceuticals Inc. stock go up soonTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Has Olema Pharmaceuticals Inc. found a price floorQuarterly Profit Report & AI Powered Market Trend Analysis - newser.com
How geopolitical tensions affect Olema Pharmaceuticals Inc. stock2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
How Olema Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Opening Moves & Fast Momentum Stock Entry Tips - fcp.pa.gov.br
Olema Pharmaceuticals, Inc. (OLMA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Olema Pharmaceuticals (OLMA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Is Olema Pharmaceuticals Inc. stock ready for breakoutInsider Buying & Weekly Market Pulse Alerts - newser.com
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals Inc Stock (OLMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Olema Pharmaceuticals Inc Stock (OLMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.04 |
10,000 |
80,400 |
754,140 |
| Harmon Cyrus | Director |
Sep 18 '25 |
Sale |
8.32 |
3,086 |
25,676 |
117,028 |
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.08 |
1,914 |
15,465 |
120,114 |
0.01%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):